Unguisin B is primarily studied for its potential therapeutic applications due to its bioactive properties. It has shown promise in research as an antimicrobial agent, particularly against certain strains of bacteria and fungi, making it a candidate for developing new antibiotics or antifungal treatments. Additionally, its anti-inflammatory properties are being explored for potential use in managing inflammatory diseases or conditions. Some studies also suggest its role in cancer research, where it may exhibit cytotoxic effects on specific cancer cell lines, indicating potential for anticancer drug development. Further research is ongoing to fully understand its mechanisms and optimize its applications in medicine.